Physician
Cardiology
Dr. Thomas G. Todaro, MD
Thomas Todaro works in the field of Cardiology. He received awards:"Fellow (FACC)". Thomas Todaro is a published physician. He has 23 publications published. The most current publication "Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction."
Publications
- Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction.
- Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coron...
- ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in...
- Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview.
- Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves.
- Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients.
- Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.
- Concerning the mechanism of pexelizumab''s benefit in acute myocardial infarction.
- Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
- Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab i...
- Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial).
- Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial.
- Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary b...
- Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial in...
- Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibit...
- Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library.
- Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI.
- Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.
- Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
- Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials.
- Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.
- Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction...
Schools
Suny Downstate Medical Center
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Nassau University Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Bhola N. Banik, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George Yiachos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haim Brandspiegel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hossain Zadeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sander Leiman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James J. Tsiakos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rose Tse, MD
This Doctor is OpenDoctor Recommended.
|